CN Stock MarketDetailed Quotes

002022 Shanghai Kehua Bio-engineering

Watchlist
  • 7.19
  • +0.01+0.14%
Noon Break Dec 12 11:30 CST
3.70BMarket Cap-10.99P/E (TTM)

Shanghai Kehua Bio-engineering Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Self-made product441.79M48.63%
Agent product437.85M48.19%
Other products28.88M3.18%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
In vitro diagnosis industry908.53M100.00%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic718.74M79.11%
Abroad189.78M20.89%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers
Symbol Price % Chg
Sprint Precision Technologies
688605
81.00 +617.45%
Jiangsu Jingxue Insulation Technology
301010
18.10 +20.03%
Global Infotech
300465
18.82 +20.03%
Hydsoft Technology
301316
25.98 +20.00%
Shanghai Fortune Techgroup
300493
22.26 +20.00%

See the daily top gainer.

Investment Theme The Concept of in Vitro Diagnosis
The Concept of in Vitro Diagnosis
Intraday+0.80%
Shenzhen Stock Exchange
Shenzhen Stock Exchange
Intraday+0.68%
Equity Transfer
Equity Transfer
Intraday+0.66%